In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo. Hoffer EP. Ann Intern Med 2020;173:JC29.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hoffer EP. In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo. Ann Intern Med 2020;173:JC29.
PMID: 32926823